UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004677 |
|---|---|
| Receipt number | R000005277 |
| Scientific Title | Phase II study of S-1 plus Bevacizumab combination chemotherapy for patients with non-small-cell lung cancer. |
| Date of disclosure of the study information | 2011/01/01 |
| Last modified on | 2017/12/12 09:12:56 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/12/07 18:24:18 | ||
| 2 | Update | 2011/12/08 22:08:31 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2015/06/27 11:34:32 | Interventions/Control_1 |
|
| 4 | Update | 2015/06/27 11:37:39 | Last name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Last name of contact person Address Address TEL |
|
| 5 | Update | 2017/12/12 09:12:56 | Recruitment status |
